rts logo

Are we looking at the next big move in Caribou Biosciences Inc (CRBU)?

Caribou Biosciences Inc (NASDAQ: CRBU) is -10.30% lower on its value in year-to-date trading and has touched a low of $3.44 and a high of $8.59 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CRBU stock was last observed hovering at around $5.12 in the last trading session, with the day’s gains setting it 0.02%.

Currently trading at $5.14, the stock is -16.68% and -18.88% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.35 million and changing 0.39% at the moment leaves the stock -9.33% off its SMA200. CRBU registered 8.67% gain for a year compared to 6-month gain of 9.59%. The firm has a 50-day simple moving average (SMA 50) of $4.71 and a 200-day simple moving average (SMA200) of -$1.44.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a -36.07% loss in the last 1 month and extending the period to 3 months gives it a -13.03%, and is -2.10% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.18% over the week and 8.16% over the month.

Caribou Biosciences Inc (CRBU) has around 158 employees, a market worth around $464.19M and $34.48M in sales. Profit margin for the company is -296.05%. Distance from 52-week low is 49.42% and -40.16% from its 52-week high. The company has generated returns on investments over the last 12 months (-25.89%).

Caribou Biosciences Inc quarterly earnings per share for the current quarter are estimated at -$0.4 with sales reaching $2.9M over the same period.The EPS is expected to shrink by -26.40% this year, but quarterly earnings will post -64.40% year-over-year. Quarterly sales are estimated to shrink -17.20% in year-over-year returns.

Caribou Biosciences Inc (CRBU) Top Institutional Holders

194 institutions hold shares in Caribou Biosciences Inc (CRBU), with institutional investors hold 91.73% of the company’s shares. The shares outstanding are 88.45M, and float is at 79.39M with Short Float at 12.69%. Institutions hold 80.33% of the Float.

The top institutional shareholder in the company is Pfm Health Sciences, Lp with over 5.57 million shares valued at $23.68 million. The investor’s holdings represent 6.31% of the CRBU Shares outstanding. As of Jun 29, 2023, the second largest holder is Blackrock Inc. with 4.76 million shares valued at $20.25 million to account for 5.40% of the shares outstanding. The other top investors are Avidity Partners Management, LP which holds 2.76 million shares representing 3.12% and valued at over $11.72 million, while Bank of America Corporation holds 3.12% of the shares totaling 2.75 million with a market value of $11.69 million.

Related Posts